AVALO THERAPEUTICS INC - COM NEW (AVTX) Institutional Ownership

CUSIP: 05338F207

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2023

Type / Class
Equity / COM NEW
Symbol
AVTX on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 05338F207?
CUSIP 05338F207 identifies AVTX - AVALO THERAPEUTICS INC - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of AVALO THERAPEUTICS INC - COM NEW (AVTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$158,937 0
2023 Q3 1,339,653 $158,937 -$574,491 $0.12 26
2023 Q2 2,426,173 $861,717 -$11,897,998 $0.36 24
2023 Q1 9,130,207 $15,977,575 +$6,149,151 $1.75 31
2022 Q4 5,550,979 $27,984,339 +$12,113 $5.04 26
2022 Q3 5,549,375 $18,422,380 +$18,420,000 $3.32 17